Reversible lesion of the corpus callosum associated with COVID-19: A case report
Künye
Gemici, Y. I., & Tasci, I. (2021). Reversible lesion of the corpus callosum associated with COVID-19: A case report. Neurology Asia, 26(4), 821-824.Özet
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect the central nervous
system and peripheral nervous system. Major central nervous system manifestations of SARS-CoV-2
infection include seizures, meningoencephalitis, ischemic stroke, anosmia, and hypogeusia. The
reversible splenial lesion syndrome was first described in 2004. Although reversible splenial lesion
syndrome was initially recognized as a benign phenomenon, a second type of reversible splenial
lesion syndrome was identified in later years, which has a poorer prognosis and potentially serious
sequela. Reversible splenial lesion syndrome can be caused by numerous etiologies including viruses.
In this report, we present a rare case of COVID-19 with reversible splenial lesion, who presented
with ataxia and dizziness.